Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$322M |
| 2 |
UnitedHealth
UNH
|
+$233M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
International Flavors & Fragrances
IFF
|
+$171M |
| 5 |
Principal Financial Group
PFG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$714M |
| 2 |
IBM
IBM
|
+$395M |
| 3 |
Cisco
CSCO
|
+$303M |
| 4 |
Procter & Gamble
PG
|
+$290M |
| 5 |
Macy's
M
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.6% |
| 2 | Financials | 14.73% |
| 3 | Healthcare | 12.36% |
| 4 | Industrials | 10.02% |
| 5 | Consumer Discretionary | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amgen
AMGN
$225B
| $1.22B | 0.35% |
8,360,156
+307,731
| +4% | +$46.3M |
|
52
Colgate-Palmolive
CL
$73.6B
| $1.22B | 0.35% |
18,651,565
-182,953
| -1% | -$12.5M |
|
53
Stryker
SYK
$133B
| $1.22B | 0.35% |
10,174,101
-205,538
| -2% | -$23.6M |
|
54
Walmart Inc
WMT
$923B
| $1.21B | 0.35% |
52,713,174
-8,180,217
| -13% | -$191M |
|
55
AbbVie
ABBV
$440B
| $1.2B | 0.35% |
19,203,688
-450,006
| -2% | -$27.5M |
|
|
WBA
56
DELISTED
Walgreens Boots Alliance
WBA
| $1.19B | 0.34% |
14,426,921
+1,412,084
| +11% | +$117M |
|
57
Goldman Sachs
GS
$302B
| $1.19B | 0.34% |
4,959,191
+630,127
| +15% | +$128M |
|
58
Qualcomm
QCOM
$171B
| $1.18B | 0.34% |
18,059,522
-1,137,259
| -6% | -$76.4M |
|
59
Abbott
ABT
$192B
| $1.17B | 0.34% |
30,452,361
+1,676,664
| +6% | +$66.5M |
|
60
3M
MMM
$94.8B
| $1.17B | 0.34% |
7,827,394
+36,306
| +0.5% | +$5.24M |
|
|
TWX
61
DELISTED
Time Warner Inc
TWX
| $1.15B | 0.33% |
11,958,763
-507,398
| -4% | -$45.2M |
|
62
Eli Lilly
LLY
$1.09T
| $1.15B | 0.33% |
15,579,958
+415,743
| +3% | +$31M |
|
63
Cognizant
CTSH
$26.2B
| $1.15B | 0.33% |
20,446,799
-433,956
| -2% | -$23.2M |
|
64
Medtronic
MDT
$116B
| $1.13B | 0.33% |
15,926,959
-1,166,490
| -7% | -$91.6M |
|
|
CELG
65
DELISTED
Celgene Corp
CELG
| $1.11B | 0.32% |
9,616,406
+155,475
| +2% | +$17.3M |
|
66
Bristol-Myers Squibb
BMY
$130B
| $1.09B | 0.31% |
18,654,632
+132,108
| +0.7% | +$7.22M |
|
67
Amphenol
APH
$210B
| $1.07B | 0.31% |
63,699,148
-5,744,068
| -8% | -$95.7M |
|
68
Broadcom
AVGO
$1.98T
| $1.06B | 0.3% |
59,752,860
+1,571,430
| +3% | +$27.2M |
|
69
Intuitive Surgical
ISRG
$142B
| $1.05B | 0.3% |
14,865,237
-186,570
| -1% | -$13.7M |
|
70
Boeing
BA
$183B
| $1.03B | 0.3% |
6,600,487
-785,001
| -11% | -$115M |
|
71
Union Pacific
UNP
$174B
| $1.02B | 0.29% |
9,800,912
-56,049
| -0.6% | -$5.51M |
|
72
Simon Property Group
SPG
$71.4B
| $1.01B | 0.29% |
5,712,469
-100,518
| -2% | -$18.7M |
|
|
RAI
73
DELISTED
Reynolds American Inc
RAI
| $1.01B | 0.29% |
17,956,111
-719,152
| -4% | -$38.2M |
|
74
Eversource Energy
ES
$26.9B
| $994M | 0.29% |
17,995,750
+1,133,808
| +7% | +$60.6M |
|
75
Costco
COST
$421B
| $989M | 0.28% |
6,175,186
+461,238
| +8% | +$70.4M |
|
Similar funds
Bank of New York Mellon's Q4 2016 Portfolio in Review
As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
- Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
- Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
- Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
- Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
- Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.
Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.